Karl Johe - Net Worth and Insider Trading

Karl Johe Net Worth

The estimated net worth of Karl Johe is at least $5,279 dollars as of 2024-05-13. Karl Johe is the Chief Scientific Officer of Seneca Biopharma Inc and owns about 530 shares of Seneca Biopharma Inc (SNCA) stock worth over $5,279. Details can be seen in Karl Johe's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Karl Johe has not made any transactions after 2015-11-16 and currently still holds the listed stock(s).

Transaction Summary of Karl Johe

To

Karl Johe Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Karl Johe owns 2 companies in total, including Seneca Biopharma Inc (SNCA) , and Palisade Bio Inc (PALI) .

Click here to see the complete history of Karl Johe’s form 4 insider trades.

Insider Ownership Summary of Karl Johe

Ticker Comapny Transaction Date Type of Owner
SNCA Seneca Biopharma Inc 2015-11-19 director & Chief Scientific Officer
PALI Palisade Bio Inc 2006-08-30 director & CSO/Chairman

Karl Johe Latest Holdings Summary

Karl Johe currently owns a total of 1 stock. Karl Johe owns 530 shares of Seneca Biopharma Inc (SNCA) as of November 16, 2015, with a value of $5,279.

Latest Holdings of Karl Johe

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SNCA Seneca Biopharma Inc 2015-11-16 530 9.96 5,279

Holding Weightings of Karl Johe


Karl Johe Form 4 Trading Tracker

According to the SEC Form 4 filings, Karl Johe has made a total of 0 transactions in Seneca Biopharma Inc (SNCA) over the past 5 years. The most-recent trade in Seneca Biopharma Inc is the sale of 16 shares on November 16, 2015, which brought Karl Johe around $27,250.

Insider Trading History of Karl Johe

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Karl Johe Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Karl Johe Ownership Network

Ownership Network List of Karl Johe

No Data

Ownership Network Relation of Karl Johe


Karl Johe Owned Company Details

What does Seneca Biopharma Inc do?

Who are the key executives at Seneca Biopharma Inc?

Karl Johe is the director & Chief Scientific Officer of Seneca Biopharma Inc. Other key executives at Seneca Biopharma Inc include director & Executive Chairman Kenneth C Carter , director & Chief Executive Officer Richard J Daly , and Chief Financial Officer Lloyd Jones Jonathan Brian .

Seneca Biopharma Inc (SNCA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Seneca Biopharma Inc (SNCA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Seneca Biopharma Inc (SNCA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Seneca Biopharma Inc (SNCA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Seneca Biopharma Inc Insider Transactions

No Available Data

Karl Johe Mailing Address

Above is the net worth, insider trading, and ownership report for Karl Johe. You might contact Karl Johe via mailing address: 9700 Great Seneca Highway, Ste 240, Rockville Md 20850.

Discussions on Karl Johe

No discussions yet.